Resmed's (ASX:RMD) continuous positive airway pressure (CPAP) devices andmasks treat sleep apnea.
CPAP has long been thegold standard for treating obstructive sleep apnea (OSA), and ResMed is theleading global supplier.
But as of today, ResMed shares have fallen from $40.13 to $23.51,which would be 71% profits for the trade if it recovers back to $40.13.
The sell-off was triggered by disappointing gross margins andgrowing investor concerns about competition from a new wave of GLP-1weight-loss drugs.However, GLP-1 facesseveral headwinds, including supply constraints, lagging real-world efficacy,side effects, low drug compliance, high costs, and a possible lack of insurancecoverage.
Its attractive valuation currently outweighs the risks it faces.This is a great buyingopportunity for me, bought (ASX:RMD) today.
- Forums
- ASX - By Stock
- RMD
- Buy RMD now and get great upside returns in a year or two
Buy RMD now and get great upside returns in a year or two
-
-
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$33.49 |
Change
0.060(0.18%) |
Mkt cap ! $21.52B |
Open | High | Low | Value | Volume |
$33.27 | $33.55 | $33.27 | $20.33M | 608.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2226 | $33.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$33.50 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 33.290 |
1 | 500 | 33.270 |
1 | 100 | 33.250 |
1 | 500 | 33.230 |
1 | 604 | 33.100 |
Price($) | Vol. | No. |
---|---|---|
33.500 | 500 | 1 |
33.550 | 1500 | 1 |
33.580 | 50 | 1 |
33.690 | 38 | 1 |
33.750 | 150 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online